Lipocine Inc expected to post a loss of 48 cents a share - Earnings Preview

Lipocine

04/11/2024 15:46

* Lipocine Inc  LPCN.OQ   LPCN.O  is expected to show a rise
in
quarterly revenue when it reports  results on November 6
(estimated) for the period ending September 30 2024
    * The Salt Lake City Utah-based  company is expected to
report a
104.8% decrease in revenue to $151 thousand from $-3.12 million
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Lipocine Inc is for a
loss
of 48 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lipocine
Inc is
21.50​, above​ its last closing price of $6.08. ​​​

This summary was machine generated November 4 at 15:46 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)